Soleus Capital Amends Rigel Pharma Stake as of Dec 31, 2023

TL;DR

**Soleus Capital updated its Rigel Pharma stake, showing its position as of year-end 2023.**

AI Summary

Soleus Capital Master Fund, L.P. filed an amended Schedule 13G/A on February 2, 2024, indicating a change in their beneficial ownership of Rigel Pharmaceuticals Inc. common stock as of December 31, 2023. This filing, an amendment to a previous disclosure, shows that Soleus Capital Master Fund, L.P. is a significant institutional investor in Rigel Pharmaceuticals. This matters to investors because large institutional holdings can signal confidence in the company's future, but changes in these holdings can also influence stock price and market sentiment.

Why It Matters

This filing updates the public on Soleus Capital Master Fund, L.P.'s ownership in Rigel Pharmaceuticals, providing transparency on a key institutional investor's position.

Risk Assessment

Risk Level: low — This is a routine amendment filing by an institutional investor, not indicating any immediate high-risk events.

Analyst Insight

Investors should note that Soleus Capital Master Fund, L.P. remains a significant holder in Rigel Pharmaceuticals. While this filing doesn't disclose the exact number of shares or percentage owned, it confirms their continued institutional interest. Smart investors would monitor future filings for changes in ownership percentage or if Soleus Capital switches to a 13D filing, which would indicate a more active investment stance.

Key Players & Entities

• Soleus Capital Master Fund, L.P. (company) — the reporting person and institutional investor
• Rigel Pharmaceuticals Inc. (company) — the subject company whose stock is being reported
• Guy Levy (person) — a group member associated with Soleus Capital Group, LLC
• Soleus Capital Group, LLC (company) — a group member associated with the reporting entity
• Soleus Capital, LLC (company) — a group member associated with the reporting entity

FAQ

Filing Documents

• ea192417-13ga1soleus_rigel.htm (SC 13G/A) — 106KB
• 0001213900-24-009383.txt ( ) — 107KB

If this statement is filed pursuant to §§240.13d-1(b)

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J). (k) Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:

Ownership

Item 4. Ownership. Reference is made to Items 5 – 11 on the preceding pages of this Schedule 13G. Master Fund held, as of the close of business on December 31, 2023, an aggregate of 9,442,579 shares of the common stock of the Issuer. As the general partner of Master Fund, Soleus Capital, LLC may be deemed to have shared power to vote or to direct the vote and to dispose or to direct the disposition of the shares held by Master Fund. As the sole managing member of Soleus Capital, LLC, Soleus Capital Group, LLC may be deemed to have shared power to vote or to direct the vote and to dispose or to direct the disposition of the shares held by Master Fund. As the sole managing member of Soleus Capital Group, LLC, Mr. Guy Levy may be deemed to have shared power to vote or direct the vote and to dispose or to direct the disposition of the Shares held by Master Fund. Neither the filing of this Schedule 13G nor any of its contents shall be deemed to constitute an admission that Mr. Levy, Soleus Capital, LLC or Soleus Capital Group, LLC is the beneficial owner of the shares of the common stock of the Issuer referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or for any other purpose, and such beneficial ownership is expressly disclaimed, except to the extent of their respective pecuniary interests therein. 7

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class Not applicable.

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not applicable.

Certification

Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose, or with the effect, of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 8 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date: February 2, 2024 Soleus Capital Master Fund, L.P. By: Soleus Capital, LLC, its General Partner By: Soleus Capital Group, LLC, its Managing Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date: February 2, 2024 Soleus Capital, LLC By: Soleus Capital Group, LLC, its Managing Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date: February 2, 2024 Soleus Capital Group, LLC By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date: February 2, 2024 /s/ Guy Levy Name: Guy Levy Footnotes: Attention:Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001) 9 EXHIBIT A JOINT FILING AGREEMENT Soleus Capital Master Fund, L.P., a Cayman Islands exempted limited partnership, Soleus Capital, LLC, a Delaware limited liability company, Soleus Capital Group, LLC, a Delaware limited liability company, and Guy Levy, an individual, hereby agree to file jointly the statement on Schedule 13G to which this Joint Filing Agreement is attached, and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934, as amended. It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the

View Full Filing

View this SC 13G/A filing on SEC EDGAR